In this issue:
No impact of immunosuppressive therapy on COVID-related outcomes
iFAME-Fertility: Paternal IA impairs fertility
Long-term guselkumab is safe for PsA
Early control of CRP levels slows spinal radiographic progression in r-axSpA
Hand strength and dexterity impaired in PsA
Poor mental health reduces TNF inhibitor efficacy in axSpA
Similar biologic drug response regardless of radiographic status in axSpA
Early non-serious adverse events generally mild and transient with tofacitinib
Clinical management of herpes zoster in patients receiving tofacitinib treatment
Smartphone application for outcome measure reporting in patients with IA
Please login below to download this issue (PDF)